Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...

Those days and weeks after a hospitalization are often a demanding, sometimes confusing time for patients, their loved ones ...

Postdischarge adverse drug event risk is amplified by frequent medication changes, formulary substitutions, and insurance ...

Lynavoy is used to treat cholestatic pruritus, an extreme itch that affects almost 90% of patients with primary biliary ...

A TOPOGRAPH-based hierarchy stratifies biomarker–drug pairs from regulatory/positive trial evidence (tiers 1–3A) to ...

Central sensitization in chronic back pain manifested as greater unpleasantness to both pressure and sound, with stronger and more specific amplification for auditory stimuli than mechanical ...

Fiscal stress reflects rates lagging medical trend; behavioral health utilization far exceeded assumptions (30% vs 3.5%–4%), ...

This month, the Florida Department of Health dramatically reduced the eligibility for their AIDS Drug Assistance Program ...

L1, EBV and mismatch repair deficiency suggests CLDN18.2 stratification must be integrated into multi-biomarker algorithms ...

FDA approval covers adults and adolescents ≥12 years (≥88 lbs) with moderate-to-severe plaque psoriasis requiring systemic ...

Federal grant delays, cancellations, and rescissions are curtailing HIV testing, surveillance, and community engagement, ...

PREVENT risk estimation starts at age 30 and incorporates lifetime risk, enabling earlier identification of patients who ...